Comparing Toviaz vs VESIcare
Toviaz (fesoterodine) | VESIcare (solifenacin) |
|
---|
Toviaz (fesoterodine) | VESIcare (solifenacin) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Urinary Incontinence, Urinary Frequency. Toviaz may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Overactive Bladder, Urinary Incontinence, Urinary Frequency. VESIcare may also be used for purposes not listed in this medication guide. |
Related suggestions Urinary Frequency
Urinary Incontinence
|
|||||||||||||||
More about Toviaz (fesoterodine) | More about VESIcare (solifenacin) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Toviaz has an average rating of 5.2 out of 10 from a total of 74 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 38% reported a negative effect. |
VESIcare has an average rating of 5.6 out of 10 from a total of 143 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 36% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Toviaz side effects |
View all VESIcare side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Toviaz prices |
View all VESIcare prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
Other solifenacin brands include: VESIcare LS | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
7 hours |
68 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 321 drugs are known to interact with Toviaz:
|
A total of 497 drugs are known to interact with VESIcare:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
October 31, 2008 |
November 19, 2004 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Myrbetriq
Myrbetriq (mirabegron) is used to treat overactive bladder with symptoms of frequent or urgent ...
VESIcare
Vesicare is used to treat symptoms of overactive bladder such as incontinence and frequent ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Detrol
Detrol is used to treat overactive bladder symptoms of urinary frequency, urgency, and ...
Ditropan
Ditropan XL (oxybutynin extended release) is used to treat the symptoms of overactive bladder ...
Urispas
Urispas is used for dysuria, urinary frequency, urinary incontinence
Ditropan XL
Ditropan XL is used for dysuria, neurogenic detrusor overactivity, urinary frequency, urinary ...
Botox Cosmetic
Botox Cosmetic is a prescription treatment for fine lines and wrinkles. It temporarily improves the ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.